StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.70−0.03 (-1.73%)

Close on Nov 18, 2026Market cap $4.75MP/E –Yield –

Processa Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Processa Pharmaceuticals's price to book ratio was 2.3× on Jul 31, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.3× to 4.6×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20262.3×+1.2
2025Dec 31, 20251.0×+0.3
2024Dec 31, 20240.8×−0.4
2023Dec 29, 20231.1×+0.1
2022Dec 30, 20221.0×−1.8
2021Dec 31, 20212.8×−4.1
2020Dec 31, 20206.9×−4.5
2019Dec 31, 201911.4×−1.9
2018Dec 31, 201813.3×−279.8
2015Jul 31, 2015293.0×−203.3
2014Oct 31, 2014496.4×–

More Processa Pharmaceuticals figures

See a number that looks wrong?